These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

656 related items for PubMed ID: 18498909

  • 1. The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study.
    Chrysant SG, Melino M, Karki S, Lee J, Heyrman R.
    Clin Ther; 2008 Apr; 30(4):587-604. PubMed ID: 18498909
    [Abstract] [Full Text] [Related]

  • 2. Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study.
    Oparil S, Melino M, Lee J, Fernandez V, Heyrman R.
    Clin Ther; 2010 Jul; 32(7):1252-69. PubMed ID: 20678674
    [Abstract] [Full Text] [Related]

  • 3. Olmesartan/amlodipine/hydrochlorothiazide in participants with hypertension and diabetes, chronic kidney disease, or chronic cardiovascular disease: a subanalysis of the multicenter, randomized, double-blind, parallel-group TRINITY study.
    Kereiakes DJ, Chrysant SG, Izzo JL, Littlejohn T, Melino M, Lee J, Fernandez V, Heyrman R.
    Cardiovasc Diabetol; 2012 Oct 30; 11():134. PubMed ID: 23110471
    [Abstract] [Full Text] [Related]

  • 4. Antihypertensive efficacy of olmesartan medoxomil or valsartan in combination with amlodipine: a review of factorial-design studies.
    Ram CV.
    Curr Med Res Opin; 2009 Jan 30; 25(1):177-85. PubMed ID: 19210150
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of olmesartan medoxomil 40 mg/hydrochlorothiazide 12.5 mg combination therapy versus olmesartan medoxomil 40 mg monotherapy in patients with moderate to severe hypertension: a randomized, double-blind, parallel-group, multicentre, multinational, phase III study.
    Fogari R, Taddei S, Holm-Bentzen M, Baszak J, Melani L, Schumacher K.
    Clin Drug Investig; 2010 Jan 30; 30(9):581-97. PubMed ID: 20593911
    [Abstract] [Full Text] [Related]

  • 6. Subgroup analyses of an efficacy and safety study of concomitant administration of amlodipine besylate and olmesartan medoxomil: evaluation by baseline hypertension stage and prior antihypertensive medication use.
    Oparil S, Lee J, Karki S, Melino M.
    J Cardiovasc Pharmacol; 2009 Nov 30; 54(5):427-36. PubMed ID: 19730391
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of olmesartan medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylate.
    Kereiakes DJ, Neutel JM, Punzi HA, Xu J, Lipka LJ, Dubiel R.
    Am J Cardiovasc Drugs; 2007 Nov 30; 7(5):361-72. PubMed ID: 17953475
    [Abstract] [Full Text] [Related]

  • 8. Olmesartan medoxomil plus amlodipine increases efficacy in patients with moderate-to-severe hypertension after monotherapy: a randomized, double-blind, parallel-group, multicentre study.
    Barrios V, Brommer P, Haag U, Calderón A, Escobar C.
    Clin Drug Investig; 2009 Nov 30; 29(7):427-439. PubMed ID: 19499960
    [Abstract] [Full Text] [Related]

  • 9. Triple-Combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in black and non-black study participants with hypertension: the TRINITY randomized, double-blind, 12-week, parallel-group study.
    Chrysant SG, Littlejohn T, Izzo JL, Kereiakes DJ, Oparil S, Melino M, Lee J, Fernandez V, Heyrman R.
    Am J Cardiovasc Drugs; 2012 Aug 01; 12(4):233-43. PubMed ID: 22799613
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and tolerability of olmesartan medoxomil combined with amlodipine in patients with moderate to severe hypertension after amlodipine monotherapy: a randomized, double-blind, parallel-group, multicentre study.
    Volpe M, Brommer P, Haag U, Miele C.
    Clin Drug Investig; 2009 Aug 01; 29(1):11-25. PubMed ID: 19067471
    [Abstract] [Full Text] [Related]

  • 11. A titrate-to-goal study of switching patients uncontrolled on antihypertensive monotherapy to fixed-dose combinations of amlodipine and olmesartan medoxomil ± hydrochlorothiazide.
    Weir MR, Hsueh WA, Nesbitt SD, Littlejohn TJ, Graff A, Shojaee A, Waverczak WF, Qian C, Jones CJ, Neutel JM.
    J Clin Hypertens (Greenwich); 2011 Jun 01; 13(6):404-12. PubMed ID: 21649839
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
    Neutel J, Shojaee A, Maa JF.
    Adv Ther; 2012 Jun 01; 29(6):508-23. PubMed ID: 22773358
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and tolerability of fixed-dose amlodipine/olmesartan medoxomil with or without hydrochlorothiazide in Hispanic and non-Hispanic patients whose blood pressure is uncontrolled on antihypertensive monotherapy.
    Punzi H, Shojaee A, Maa JF, BP-CRUSH Investigators.
    Ther Adv Cardiovasc Dis; 2012 Aug 01; 6(4):149-61. PubMed ID: 22855062
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial.
    Sohn IS, Kim CJ, Oh BH, Hong TJ, Park CG, Kim BS, Chung WB, Investigators.
    Am J Cardiovasc Drugs; 2016 Apr 01; 16(2):129-38. PubMed ID: 26691333
    [Abstract] [Full Text] [Related]

  • 15. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T, Smith TR, Glazer R, Wernsing M, Yen J, Jin J, Schneider H, Pospiech R.
    Clin Ther; 2007 Apr 01; 29(4):563-80. PubMed ID: 17617280
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of olmesartan medoxomil/amlodipine fixed-dose combination for hypertensive patients uncontrolled with monotherapy.
    Zhu JR, Zhang SY, Gao PJ.
    Arch Pharm Res; 2014 Dec 01; 37(12):1588-98. PubMed ID: 25060946
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of amlodipine/olmesartan medoxomil ± HCTZ in obese patients uncontrolled on antihypertensive monotherapy.
    Hsueh WA, Shojaee A, Maa JF, Neutel JM.
    Curr Med Res Opin; 2012 Nov 01; 28(11):1809-18. PubMed ID: 23072496
    [Abstract] [Full Text] [Related]

  • 18. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K, Ogihara T, Saruta T, Kuramoto K, REZALT Study Group.
    Clin Ther; 2010 May 01; 32(5):861-81. PubMed ID: 20685495
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Rakugi H, Ogihara T, Miyata Y, Sasai K, Totsuka N.
    Clin Ther; 2012 Apr 01; 34(4):838-48. PubMed ID: 22440192
    [Abstract] [Full Text] [Related]

  • 20. Triple-combination treatment with olmesartan medoxomil/amlodipine/ hydrochlorothiazide in Hispanic/Latino patients with hypertension: the TRINITY study.
    Lewin AJ, Kereiakes DJ, Chrysant SG, Izzo JL, Oparil S, Lee J, Fernandez V, Melino M.
    Ethn Dis; 2014 Apr 01; 24(1):41-7. PubMed ID: 24620447
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.